Reema K Thalji

Title: Reema K Thalji: Innovator in sEH Inhibitors

Introduction

Reema K Thalji is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of sEH inhibitors. With a total of 3 patents to her name, her work is paving the way for new treatments for diseases mediated by the sEH enzyme.

Latest Patents

Thalji's latest patents focus on novel sEH inhibitors and their applications in treating various diseases. One of her key inventions is directed towards compounds such as (Cis)-N-{[4-cyano-2-(trifluoromethyl)phenyl]methyl}-3-{[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino}cyclohexanecarboxamide and its pharmaceutically acceptable salts. These compounds are designed to inhibit sEH and can be utilized in treating conditions like hypertension. Additionally, her inventions include pharmaceutical compositions that incorporate these compounds, along with methods for inhibiting sEH and treating associated conditions.

Career Highlights

Reema K Thalji is currently employed at GlaxoSmithKline LLC, where she continues to innovate in the pharmaceutical sector. Her work has garnered attention for its potential impact on healthcare and disease management.

Collaborations

Thalji collaborates with notable colleagues, including Yun Ding and Joseph P Marino, Jr. These partnerships enhance her research and development efforts, contributing to the advancement of her inventions.

Conclusion

Reema K Thalji is a trailblazer in the field of sEH inhibitors, with a focus on developing innovative treatments for diseases. Her contributions are significant in the pharmaceutical industry, and her work continues to inspire future advancements.